Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Letrozole for Treatment of Uterine Fibroids: A Randomized, Placebo-Controlled Trial

NCT06143631 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06143631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06143631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Letrozole for Treatment of Uterine Fibroids: A Randomized, Placebo-Controlled Trial
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Recruiting
Start date
July 24, 2024
Completion date
December 11, 2028
Enrollment
140 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

fibroid, fibroid uterus, leiomyoma, leiomyoma, uterine